RESEARCH PROGRESS OF GLOMERULAR ENDOTHELIAL CELL-PODOCYTE INTERACTION IN DN PATIENTS

被引:1
|
作者
Wan, Xiaoyun [1 ,2 ]
Zhang, Fang [1 ,2 ]
Liu, Chao [1 ,2 ]
机构
[1] Nanjing Univ Tradit Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing 210028, Jiangsu, Peoples R China
[2] Jiangsu Prov Acad Tradit Chinese Med, Nanjing 210028, Jiangsu, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2020年 / 36卷 / 06期
关键词
DN; endothelial cell; podocyte; interaction; DIABETIC-NEPHROPATHY; MESANGIAL CELL; INJURY; EXPRESSION; ALBUMINURIA; DYSFUNCTION; FRAMEWORK; MODEL;
D O I
10.19193/0393-6384_2020_6_592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic Nephropathy (DN) is one of important pathogeneses resulting in endstage renal disease, seriously affects patients' living quality and threatens life safety. Deeply exploring DN pathogenesis and seeking a more effective treatment method to improve patients' clinical prognosis have become a hot issue in the medical field. The early report holds that podocyte damage has close relations with DN occurrence and development. Recent studies verify that glomerular endothelial cell damage also participates in DN progress. Podocytes and glomerular endothelial cells have many same signal regulation paths, so their interaction has been proven to be a potential important mechanism of DN onset. After DN patients' podocytes are damaged, the secretion of multiple signal molecules including VEGF and Ang-1 is abnormal. Meanwhile, damaged glomerular endothelial cells can synthesize and secrete HGF, IGFBPs and other cytokines which will also influence podocyte functions, thus leading to the changes in the structure and function of podocytes to different degrees. Based on the above evidence, exploring the interaction between glomerular endothelial cells and podocytes has important value for further specifting DN pathogenesis and determining a better treatment strategy.
引用
收藏
页码:3737 / 3742
页数:6
相关论文
共 45 条
  • [31] INTERACTION BETWEEN PLATELET AND ENDOTHELIAL-CELL MATRIX (ECM) IN PATIENTS WITH BREAST-CANCER - EFFECT OF CHEMOTHERAPY
    ORLANDO, E
    MARCHETTI, M
    FALANGA, A
    BARBUI, T
    THROMBOSIS RESEARCH, 1993, 70 : S79 - S79
  • [32] Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behcet disease
    Treudler, R
    Zouboulis, CC
    Buttner, P
    Detmar, M
    Orfanos, CE
    ARCHIVES OF DERMATOLOGY, 1996, 132 (11) : 1323 - 1329
  • [33] The effect of reactive oxygen species on whole blood aggregation and the endothelial cell-platelet interaction in patients with coronary heart disease
    Watt, Jonathan
    Ewart, Marie-Ann
    Greig, Fiona H.
    Oldroyd, Keith G.
    Wadsworth, Roger M.
    Kennedy, Simon
    THROMBOSIS RESEARCH, 2012, 130 (02) : 210 - 215
  • [34] Effects of carvedilol on peripheral markers of monocyte-endothelial cell adhesive interaction in patients with post-infarction cardiac dysfunction
    Parissis, J. T.
    Adamopoulos, S.
    Kostakis, G.
    Rigas, A.
    Venetsanou, K.
    Karas, S.
    Kremastinos, D.
    EUROPEAN HEART JOURNAL, 2005, 26 : 729 - 729
  • [36] LEUCOCYTE-ENDOTHELIAL CELL-INTERACTION - INAUGURAL MEETING OF THE BRITISH-INFLAMMATION-RESEARCH-ASSOCIATION (BIRAS) 7TH JUNE, 1988
    HARPER, GP
    AGENTS AND ACTIONS, 1989, 28 (3-4): : 235 - 237
  • [37] Adhesion Molecules Interaction with Markers of Lipid Metabolism, Hemolysis, Endothelial Dysfunction and Medical Histories Among Steady-State Sickle Cell Anemia Patients.
    Veloso Cerqueira, Bruno Antonio, Sr.
    Boas, Wendell Vilas, Sr.
    Clarencio, Jorge, Sr.
    Andrade, Daniela, Jr.
    Zanette, Angela M. D.
    Reis, Mitermayer Galvao
    Moura Neto, Jose, Sr.
    Cesar, Rodrigo Silva, Sr.
    Goncalves, Marilda Souza
    BLOOD, 2009, 114 (22) : 1002 - 1002
  • [38] INCREASED EXPRESSION OF P-SELECTIN IN CORONARY ATHERECTOMY SPECIMENS FROM PATIENTS WITH UNSTABLE ANGINA - EVIDENCE FOR LEUKOCYTE-ENDOTHELIAL CELL-INTERACTION IN UNSTABLE ANGINA
    TENAGLIA, AN
    BUDA, AJ
    WILKINS, RG
    BARRON, MK
    JEFFORDS, PR
    VO, K
    JORDAN, MO
    KUSNICK, BA
    LEFER, DJ
    CIRCULATION, 1995, 92 (08) : 1622 - 1622
  • [39] Recent progress in cytokine therapy for renal cell cancer: a case for the European Organization for Research and Treatment of Cancer adjuvant cytokine trial in patients with poor-risk renal cell cancer after maximum debulking surgery
    Ravi, R
    Oliver, RTD
    BJU INTERNATIONAL, 1999, 83 (03) : 219 - 221
  • [40] An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
    Gruenwald, Viktor
    Karakiewicz, Pierre I.
    Bavbek, Sevil E.
    Miller, Kurt
    Machiels, Jean-Pascal
    Lee, Se-Hoon
    Larkin, James
    Bono, Petri
    Rha, Sun Young
    Castellano, Daniel
    Blank, Christian U.
    Knox, Jennifer J.
    Hawkins, Robert
    Anak, Oezlem
    Rosamilia, Marianne
    Booth, Jocelyn
    Pirotta, Nicoletta
    Bodrogi, Istvan
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (03) : 324 - 332